Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 763

  • The following terms were not found in PubMed: cancer%5BTitle%2FAbstract%5D, dna%5BTitle%2FAbstract%5D.
1.

Mutational Mosaics of Cell-Free DNA from Pancreatic Cyst Fluids.

Paziewska A, Polkowski M, Goryca K, Karczmarski J, Wiechowska-Kozlowska A, Dabrowska M, Mikula M, Ostrowski J.

Dig Dis Sci. 2020 Jan 10. doi: 10.1007/s10620-019-06043-1. [Epub ahead of print]

PMID:
31925676
2.

4-(4-Chlorophenyl)thiazol-2-amines as pioneers of potential neurodegenerative therapeutics with anti-inflammatory properties based on dual DNase I and 5-LO inhibition.

Smelcerovic A, Zivkovic A, Ilic BS, Kolarevic A, Hofmann B, Steinhilber D, Stark H.

Bioorg Chem. 2019 Dec 20;95:103528. doi: 10.1016/j.bioorg.2019.103528. [Epub ahead of print]

PMID:
31918397
3.

Circulating unmethylated insulin DNA as a biomarker of human beta cell death: a multi-laboratory assay comparison.

Speake C, Ylescupidez A, Neiman D, Shemer R, Glaser B, Tersey SA, Usmani-Brown S, Clark P, Wilhelm JJ, Bellin MD, Herold KC, Mirmira RG, Dor Y, Evans-Molina C.

J Clin Endocrinol Metab. 2020 Jan 8. pii: dgaa008. doi: 10.1210/clinem/dgaa008. [Epub ahead of print]

PMID:
31913467
4.

Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery.

Brancaccio M, Natale F, Falco G, Angrisano T.

Genes (Basel). 2019 Dec 23;11(1). pii: E14. doi: 10.3390/genes11010014. Review.

5.

Circulating tumor DNA as an early cancer detection tool.

Campos-Carrillo A, Weitzel JN, Sahoo P, Rockne R, Mokhnatkin JV, Murtaza M, Gray SW, Goetz L, Goel A, Schork N, Slavin TP.

Pharmacol Ther. 2019 Dec 18:107458. doi: 10.1016/j.pharmthera.2019.107458. [Epub ahead of print] Review.

PMID:
31863816
6.

KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients.

Wang ZY, Ding XQ, Zhu H, Wang RX, Pan XR, Tong JH.

Front Oncol. 2019 Nov 29;9:1295. doi: 10.3389/fonc.2019.01295. eCollection 2019.

7.

Highly specific enrichment of rare nucleic acid fractions using Thermus thermophilus argonaute with applications in cancer diagnostics.

Song J, Hegge JW, Mauk MG, Chen J, Till JE, Bhagwat N, Azink LT, Peng J, Sen M, Mays J, Carpenter EL, van der Oost J, Bau HH.

Nucleic Acids Res. 2019 Dec 12. pii: gkz1165. doi: 10.1093/nar/gkz1165. [Epub ahead of print]

PMID:
31828328
8.

Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models.

Hisada Y, Mackman N.

Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):182-186. doi: 10.1182/hematology.2019000025.

PMID:
31808871
9.

DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients.

Vrba L, Oshiro MM, Kim SS, Garland LL, Placencia C, Mahadevan D, Nelson MA, Futscher BW.

Epigenetics. 2019 Nov 27:1-12. doi: 10.1080/15592294.2019.1695333. [Epub ahead of print]

PMID:
31775567
10.

A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study).

Yoshida Y, Yamada T, Matsuoka H, Sonoda H, Fukazawa A, Yoshida H, Ishida H, Hirata K, Hasegawa S, Sakamoto K, Otsuka T, Koda K.

J Anus Rectum Colon. 2019 Jul 30;3(3):136-141. doi: 10.23922/jarc.2018-043. eCollection 2019.

11.

Liquid biopsy assessment of synchronous malignancies: a case report and review of the literature.

Liebs S, Nonnenmacher A, Klauschen F, Keilholz U, Vecchione L.

ESMO Open. 2019 Aug 16;4(4):e000528. doi: 10.1136/esmoopen-2019-000528. eCollection 2019. Review.

12.

Liquid biopsies in pancreatic cancer.

Kamyabi N, Bernard V, Maitra A.

Expert Rev Anticancer Ther. 2019 Oct;19(10):869-878. doi: 10.1080/14737140.2019.1670063. Epub 2019 Sep 26.

PMID:
31533487
13.

Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis.

Natale F, Vivo M, Falco G, Angrisano T.

Clin Epigenetics. 2019 Sep 6;11(1):132. doi: 10.1186/s13148-019-0728-8. Review.

14.

Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cells.

Takeda K, Yamada T, Takahashi G, Iwai T, Ueda K, Kuriyama S, Koizumi M, Matsuda A, Shinji S, Ohta R, Yokoyama Y, Hotta M, Hara K, Yoshida H.

Cancer Sci. 2019 Nov;110(11):3497-3509. doi: 10.1111/cas.14186. Epub 2019 Sep 18.

15.

Circulating cell-free long DNA fragments predict post-hepatectomy recurrence of colorectal liver metastases.

Iwai T, Yamada T, Takahashi G, Takeda K, Koizumi M, Shinji S, Matsuda A, Yokoyama Y, Hara K, Ueda K, Ohta R, Taniai N, Yoshida H.

Eur J Surg Oncol. 2020 Jan;46(1):108-114. doi: 10.1016/j.ejso.2019.08.010. Epub 2019 Aug 12.

PMID:
31431321
16.

Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer.

Mohan S, Ayub M, Rothwell DG, Gulati S, Kilerci B, Hollebecque A, Sun Leong H, Smith NK, Sahoo S, Descamps T, Zhou C, Hubner RA, McNamara MG, Lamarca A, Valle JW, Dive C, Brady G.

Sci Rep. 2019 Aug 12;9(1):11610. doi: 10.1038/s41598-019-47489-7.

17.

Simvastatin induces autophagic flux to restore cerulein-impaired phagosome-lysosome fusion in acute pancreatitis.

Piplani H, Marek-Iannucci S, Sin J, Hou J, Takahashi T, Sharma A, de Freitas Germano J, Waldron RT, Saadaeijahromi H, Song Y, Gulla A, Wu B, Lugea A, Andres AM, Gaisano HY, Gottlieb RA, Pandol SJ.

Biochim Biophys Acta Mol Basis Dis. 2019 Nov 1;1865(11):165530. doi: 10.1016/j.bbadis.2019.08.006. Epub 2019 Aug 6.

PMID:
31398467
18.

Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma.

Strijker M, Soer EC, de Pastena M, Creemers A, Balduzzi A, Beagan JJ, Busch OR, van Delden OM, Halfwerk H, van Hooft JE, van Lienden KP, Marchegiani G, Meijer SL, van Noesel CJ, Reinten RJ, Roos E, Schokker S, Verheij J, van de Vijver MJ, Waasdorp C, Wilmink JW, Ylstra B, Besselink MG, Bijlsma MF, Dijk F, van Laarhoven HW.

Int J Cancer. 2020 Mar 1;146(5):1445-1456. doi: 10.1002/ijc.32586. Epub 2019 Aug 13.

PMID:
31340061
19.

Comparative analysis of diagnostic platforms for measurement of differentially methylated insulin DNA.

Farr RJ, Wong WKM, Maynard CL, Tersey SA, Mirmira RG, Hardikar AA, Joglekar MV.

J Biol Methods. 2019;6(2). pii: e113. doi: 10.14440/jbm.2019.280. Epub 2019 Jun 3.

20.

Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma.

Loft M, Lee B, Tie J, Gibbs P.

J Pers Med. 2019 Jul 18;9(3). pii: E37. doi: 10.3390/jpm9030037. Review.

Supplemental Content

Loading ...
Support Center